CX Daily: Sinovac’s Covid Fortune Fuels Bitter Boardroom Battle
TOP STORIES Sinovac / In Depth: Sinovac’s Covid fortune fuels bitter boardroom battle The Covid-19 pandemic turned Chinese vaccine-maker Sinovac...
275 Views
Beijing Wantai Biological (603392.CH) - After A 3839% Rally, Let's Look at Some Concerns
Behind the outstanding performance in stock price,there could be some concerns that deserve to pay attention to in business side, financial...
369 Views
The Week That Was in ASEAN@Smartkarma - OTT's Back, Indonesian Consumer Health, and Lippo Karawaci
The week that was in ASEAN@Smartkarma is filled with another eclectic mix of differentiated, substantive, and actionable insights from across South...
345 Views
Industry Report - Insights on China Vaccine Industry
The article analyzed China vaccine industry in terms of market potential, key vaccine varieties such as PCV13, influenza vaccine, HPV vaccine,...
413 Views
The Week that Was in ASEAN@Smartkarma - Digital Festive Cheer, Sea Ltd Going Financial, and KEX
The week that was in ASEAN@Smartkarma is filled with another eclectic mix of differentiated, substantive, and actionable insights from across South...
314 Views